| | | | Western blot - MMP1 antibody - Amino end of active enzyme (ab38925)  (enlarge) | |
| |
| Product Name | MMP1 antibody - Aminoterminal end active enzyme |
| | See all MMP1 antibodies (24)... |
| Product type | Primary antibodies |
| Description | Rabbit polyclonal to MMP1 - Aminoterminal end active enzyme |
| Immunogen | Synthetic peptide based on the aminoterminal region of Human MMP1.
(Peptide available as ab41019.) |
| Reacts with (species key) | Hu |
| Specificity | ab38925 binds to reduced MMP1 but less well to non-reduced MMP1. It does not cross react with the other MMP family members (MMP2, MMP3, MMP9, etc.). It reacts with latent and active MMP1. We have a range of domain specific antibodies for this target. For a full list please see all MMP1 antibodies |
| Tested applications (see key) | WB |
|
| Abreviews | |
|
| Application notes (see key) | Recommended dilutions WB: A recommended starting concentration for Western blots is 1:1000 when using colorimetric substrates such as BCIP/NBT, and 1:5000 for chemiluminescent substrates. Although the sequence homology for this portion of MMP-1 is well conserved, higher concentrations of antibody may be needed for non-human samples. RP4C1 recognizes both active and latent forms of MMP-1. Collagenase levels in quiescent cells and tissues are minimal, and stimulation or protein concentration is often needed to visualize the bands. In addition, cell types differ greatly in the quantity of Collagenase produced. Detects a band of approximately 51-53 kDa (predicted molecular weight: 54 kDa). Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user. |
| Positive control (see definition) | Cell media from human chondrosarcoma treated with TPA. |
| Cellular localization | Secreted |
| Research areas | Cardiovascular >> Atherosclerosis >> Thrombosis >> Endothelial mediators/regulators Cancer >> Tumor biomarkers >> Enzymes >> MMPs Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> MMPs Cancer >> Invasion/microenvironment >> Angiogenesis >> ECM enzymes >> MMPs Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> MMP Cardiovascular >> Angiogenesis >> Adhesion / ECM >> Matrix Metalloproteinases >> MMP |
| Relevance | The matrix metalloproteinases (MMPs) are a family of at least eighteen secreted and membrane bound zincendopeptidases. Collectively, these enzymes can degrade all the components of the extracellular matrix, including fibrillar and non fibrillar collagens, fibronectin, laminin and basement membrane glycoproteins. In general, a signal peptide, a propeptide, and a catalytic domain containing the highly conserved zinc binding site characterizes the structure of the MMPs. In addition, fibronectin like repeats, a hinge region, and a C terminal hemopexin like domain allow categorization of MMPs into the collagenase, gelatinase, stomelysin and membrane type MMP subfamilies. All MMPs are synthesized as proenzymes, and most of them are secreted from the cells as proenzymes. Thus, the activation of these proenzymes is a critical step that leads to extracellular matrix breakdown. MMPs are considered to play an important role in wound healing, apoptosis, bone elongation, embryo development, uterine involution, angiogenesis and tissue remodeling, and in diseases such as multiple sclerosis, Alzheimer's, malignant gliomas, lupus, arthritis, periodontis, glumerulonephritis, atherosclerosis, tissue ulceration, and in cancer cell invasion and metastasis.
MMP1, also known as interstitial collagenase, is the only enzyme that is able to initiate the breakdown of the interstitial collagens, types I, II, and III. |
| | |
| Database links | The links below go to external sites and will open in a new browser window |
| Raised in | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Purity | Immunogen affinity purified |
| Storage buffer | Preservative: Sodium Azide Constituents: 50% Glycerol Material safety datasheets (MSDS) for this product: Glycerol MSDS Sodium Azide MSDS
|
| Form | Liquid |
| Concentration | 1.000 mg/ml |
| Storage instructions | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles. |
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this MMP1 antibody - Aminoterminal end active enzyme is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| See below for MMP1 antibody - Aminoterminal end active enzyme images, references, products related to ab38925 and other tools. |
| |
MMP1 antibody - Aminoterminal end active enzyme images: |
Western blot - MMP1 antibody - Amino end of active enzyme (ab38925) All lanes : MMP1 antibody - Aminoterminal end active enzyme (ab38925) at 1/1000 dilution
Lane 1 : Human MMP 1 Lane 2 : Cell media from Human chondrosarcoma (no treatment) Lane 3 : Cell media from Human chondrosarcoma (treated with TPA)
Performed under reducing conditions.
Predicted band size : 54 kDa Observed band size : 51-53 kDa (why is the actual band size different from the predicted?)
|
| |
| |
| Search PubMed (MEDLINE) for references to MMP1 |
| |
MMP1 antibody - Aminoterminal end active enzyme - more information |
Customer reviews (feedback) regarding MMP1 antibody - Aminoterminal end active enzyme |
Customer FAQs regarding MMP1 antibody - Aminoterminal end active enzyme |
Protocols for MMP1 antibody - Aminoterminal end active enzyme |
Price and availability of products related to MMP1 antibody - Aminoterminal end active enzyme |
| |
MMP1 antibody - Aminoterminal end active enzyme - related products: |
| |
| |
MMP1 antibody - Aminoterminal end active enzyme - other tools: |
Contact Abcam with a Technical Enquiry about MMP1 antibody - Aminoterminal end active enzyme |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"